Exhibit 5.2
![LOGO](https://capedge.com/proxy/F-3ASR/0001193125-21-231624/g159457dsp1.jpg)
PARTNERSHIP CONSTITUEE SELON LE DROIT DE L’OHIO, USA
AVOCATS AU BARREAU DE PARIS
2, RUE SAINT-FLORENTIN • 75001 PARIS
TELEPHONE: (0)1.56.59.39.39 • FACSIMILE: (0)1.56.59.39.38 • TOQUE J 001
WWW.JONESDAY.COM
July 30, 2021
SANOFI
54, rue La Boétie
75008 Paris, France
Re: Registration Statement on Form F-3 Filed by Sanofi
Ladies and Gentlemen:
We have acted as United States counsel for Sanofi, a French société anonyme (the “Company”), in connection with the authorization of the issuance and sale from time to time, on a delayed basis, by the Company of an indeterminate amount of debt securities of the Company (the “Debt Securities”), in one or more series, as contemplated by the Registration Statement on Form F-3 to which this opinion is filed as an exhibit (as the same may be amended from time to time, the “Registration Statement”). The Debt Securities may be offered and sold from time to time pursuant to Rule 415 under the Securities Act of 1933 (the “Securities Act”).
In connection with the opinion expressed herein, we have examined such documents, records and matters of law as we have deemed relevant or necessary for purposes of such opinion.
Based on the foregoing, and subject to the further limitations, qualifications and assumptions set forth herein, we are of the opinion that the Debt Securities, upon receipt by the Company of such lawful consideration therefore as the conseil d’administration (board of directors) of the Company (and/or the directeur général (chief executive officer) of the Company or the directeur financier (chief financial officer) of the Company) may determine, will constitute valid and binding obligations of the Company.
The opinion set forth above is subject to the following limitations, qualifications and assumptions:
In rendering the foregoing opinion, we have assumed that: (i) the Registration Statement, and any amendments thereto, will have become effective under the Securities Act (and will remain effective at the time of issuance of any Debt Securities thereunder); (ii) a prospectus supplement describing each series of Debt Securities offered pursuant to the Registration Statement, to the extent required by applicable law and relevant rules and regulations of the United States Securities and Exchange Commission (the “Commission”), will be timely filed with the Commission; (iii) the definitive terms of each series of Debt Securities will have been established in accordance with all requisite corporate action and
BUREAUX : AL-KHOBAR ● AMSTERDAM ● ATLANTA ● BOSTON ● BRISBANE ● BRUXELLES ● CHICAGO ● CLEVELAND ● COLUMBUS ● DALLAS
DETROIT ● DUBAÏ ● DÜSSELDORF ● FRANCFORT ● HONG KONG ● HOUSTON ● IRVINE ● LONDRES ● LOS ANGELES ● MADRID ● MELBOURNE
MEXICO CITY ● MIAMI ● MILAN ● MINNEAPOLIS ● MOSCOU ● MUNICH ● NEW YORK ● PARIS ● PÉKIN ● PERTH ● PITTSBURGH ● RIYAD
SAN DIEGO ● SAN FRANCISCO ● SÃO PAULO ● SHANGHAÏ ● SILICON VALLEY ● SINGAPOUR ● SYDNEY ● TAÏPEI ● TOKYO ● WASHINGTON